FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Go back to FDA Approves New Prostate Cancer Imaging Agent Gozellix®
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.00 --0 (-0%)
Previous Close $12.00    52 Week High $2.18 
Open $12.00    52 Week Low $0.30 
Day High $12.00    P/E N/A 
Day Low $12.00    EPS $-3.32 
Volume 565       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.00 --0 (-0%)
Previous Close $12.00    52 Week High $2.18 
Open $12.00    52 Week Low $0.30 
Day High $12.00    P/E N/A 
Day Low $12.00    EPS $-3.32 
Volume 565